Observed outcomes during follow-up of the study cohort
| Patient characteristics | n (%)* |
|---|---|
| All analysed lung transplant recipients | 198 (100) |
| Deaths during follow-up | 26 (13.1) |
| Patients with an event of GR | 35 (17.7) |
| CF | 17 (48,5) |
| With diabetes | 12 (34) |
| COPD | 7 (20) |
| With diabetes | 1 (3) |
| IPF | 6 (17) |
| Others | 5 (14.5) |
| With diabetes | 2 (6) |
| Patients with any lower gastrointestinal event† | 165 (83.3) |
| Small bowel obstruction | 13‡ (7.5) |
| Large bowel obstruction | 14 (7.1) |
| Coprostasis | 124 (62.6) |
| Diffuse bowel obstruction | 13 (6.6) |
| Bowel perforation | 1 (0.5) |
| Patients with up to 3 lower GI events | 138 (69.7) |
| Patients with >3 repetitive lower GI events | 79 (39.9) |
| Patients with an event of bronchiolitis obliterans syndrome | 52 (26.7) |
*Results given as number (%) unless indicated otherwise.
†Patients may have more than one different lower GI event. The sum of lower GI events therefore exceeds the number of patients with any lower gastrointestinal event.
‡One patient with ileus as complication.
BOS, bronchiolitis obliterans syndrome; GI, gastrointestinal.